News25/Ratings12
News · 26 weeks450%
2025-10-262026-04-19
Mix2190d
- Insider9(43%)
- Other4(19%)
- Analyst4(19%)
- SEC Filings3(14%)
- Earnings1(5%)
Latest news
25 items- PRDoximity to Release Fiscal 2026 Fourth Quarter and Full Year Results on May 13, 2026Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal fourth quarter and full year ended March 31, 2026 after market close on May 13, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network membe
- ANALYSTDoximity downgraded by Truist with a new price targetTruist downgraded Doximity from Buy to Hold and set a new price target of $29.00
- SECDoximity Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure8-K - Doximity, Inc. (0001516513) (Filer)
- INSIDERSEC Form 4 filed by Sitaram Siddharth4 - Doximity, Inc. (0001516513) (Issuer)
- ANALYSTDoximity downgraded by Evercore ISI with a new price targetEvercore ISI downgraded Doximity from Outperform to In-line and set a new price target of $25.00
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Doximity Inc.SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)
- PRDoximity Study Finds Physicians Rapidly Adopting AI, But Accuracy Concerns Persist94% of physicians are using AI or interested, but 71% are concerned about its accuracy and reliability Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today released a new report examining how physicians are adopting artificial intelligence (AI) in clinical practice. The findings show that AI adoption and interest are widespread: 94% of physicians reported they are currently using AI or interested in doing so. At the same time, physicians remain cautious, with 71% citing accuracy and reliability as their top concern. "AI has quickly become a meaningful part of physicians' daily workflows," said Amit Phull, MD, chief clinical experience officer at
- INSIDERInterim PFO and PAO Sitaram Siddharth converted options into 5,000 shares and sold $58,833 worth of shares (2,319 units at $25.37), increasing direct ownership by 3% to 84,132 units (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERInterim PFO and PAO Sitaram Siddharth converted options into 5,000 shares and sold $63,622 worth of shares (2,282 units at $27.88), increasing direct ownership by 3% to 81,451 units (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERDirector Wampler Kira Scherer converted options into 2,000 shares and sold $52,000 worth of shares (2,000 units at $26.00) (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERInterim PFO and PAO Sitaram Siddharth covered exercise/tax liability with 946 shares and was granted 10,376 shares, increasing direct ownership by 14% to 78,733 units (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERChief Financial Officer Bryson Anna was granted 152,258 shares and covered exercise/tax liability with 11,381 shares, increasing direct ownership by 39% to 505,549 units (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERChief Executive Officer Tangney Jeffrey covered exercise/tax liability with 8,243 shares, decreasing direct ownership by 0.37% to 2,232,810 units (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- INSIDERNew insider Sitaram Siddharth claimed ownership of 69,303 shares (SEC Form 3)3 - Doximity, Inc. (0001516513) (Issuer)
- ANALYSTDoximity upgraded by Canaccord Genuity with a new price targetCanaccord Genuity upgraded Doximity from Hold to Buy and set a new price target of $34.00
- ANALYSTDoximity upgraded by Analyst with a new price targetAnalyst upgraded Doximity from Underweight to Neutral and set a new price target of $40.00
- SECSEC Form 10-Q filed by Doximity Inc.10-Q - Doximity, Inc. (0001516513) (Filer)
- PRDoximity Ranked #1 Best in KLAS Telehealth Video Platform for Fifth Consecutive YearDoximity Dialer earns A-level ratings in all categories Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, announced today that Doximity Dialer has been named the #1 Telehealth Video Conferencing Platform in the 2026 Best in KLAS Report. This is the fifth consecutive year that Doximity has earned the top spot, underscoring its position as a trusted, long-term partner for physicians and health systems. In addition to securing the #1 spot, Doximity received A-level ratings in all categories, including A+ ratings for culture, loyalty and value. These results are based on live interviews with health system leaders and their staff, reflecting high satisf
- SECDoximity Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Financial Statements and Exhibits8-K - Doximity, Inc. (0001516513) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Doximity Inc.SCHEDULE 13G/A - Doximity, Inc. (0001516513) (Subject)
- INSIDERDirector Wampler Kira Scherer converted options into 2,000 shares and sold $74,660 worth of shares (2,000 units at $37.33) (SEC Form 4)4 - Doximity, Inc. (0001516513) (Issuer)
- ANALYSTDoximity upgraded by Wells Fargo with a new price targetWells Fargo upgraded Doximity from Equal Weight to Overweight and set a new price target of $55.00
- PRDoximity to Release Fiscal 2026 Third Quarter Results on February 5, 2026Doximity, Inc. (NYSE:DOCS), the leading digital platform for U.S. medical professionals, today announced it will report financial results for its fiscal third quarter ended December 31, 2025 after market close on February 5, 2026. Doximity will host a conference call and webcast at 2:00 p.m. PT (5:00 p.m. ET) to discuss the financial results. To listen to a live audio webcast, please visit the Company's Investor Relations page at https://investors.doximity.com/ before the call. A webcast replay will be available on the website following the call. About Doximity Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members inclu
- ANALYSTRBC Capital Mkts initiated coverage on Doximity with a new price targetRBC Capital Mkts initiated coverage of Doximity with a rating of Outperform and set a new price target of $59.00
- ANALYSTDoximity upgraded by TruistTruist upgraded Doximity from Hold to Buy